首页> 外国专利> HARD CAPSULE FORMULATION COMPRISING MEMANTINE WITH IMMEDIATE AND SUSTAINED RELEASE PROPERTIES AND MANUFACTURING METHOD THEREOF

HARD CAPSULE FORMULATION COMPRISING MEMANTINE WITH IMMEDIATE AND SUSTAINED RELEASE PROPERTIES AND MANUFACTURING METHOD THEREOF

机译:具有中度和持续释放特性的金属硬质胶囊制剂及其制造方法

摘要

An aspect is a hard capsule formulation comprising an immediate release part in a tablet form comprising memantine or a pharmaceutically acceptable salt thereof and a sustained release part in the tablet form comprising memantine or the pharmaceutically acceptable salt thereof, which provides: the hard capsule formulation, wherein a dissolution rate of memantine or the pharmaceutically acceptable salt thereof is 30 to 50% in an hour, and 40 to 60% in two hours; and a manufacturing method thereof. The hard capsule formulation according to the aspect comprises the immediate release part and the sustained release part at the same time, thereby having excellent initial bioavailability and having sustained release characteristics to increase patient compliance with medication. Therefore, the hard capsule formulation can be usefully used as a prophylactic or therapeutic agent for early and severe Alzheimers disease.;COPYRIGHT KIPO 2019
机译:一个方面是硬胶囊制剂,其包含包含美金刚或其药学上可接受的盐的片剂形式的速释部分和包含美金刚或其药学上可接受的盐的片剂形式的缓释部分,其提供:硬胶囊制剂,其中美金刚或其药学上可接受的盐的溶出度在一小时内为30至50%,在两小时内为40至60%。及其制造方法。根据该方面的硬胶囊制剂同时包含立即释放部分和持续释放部分,从而具有优异的初始生物利用度并且具有持续释放特性以增加患者对药物的依从性。因此,硬胶囊制剂可以有效地用作早期和严重阿尔茨海默氏病的预防或治疗剂。; COPYRIGHT KIPO 2019

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号